BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 11, 2016
View Archived Issues
FDA grants orphan drug designation to JCAR-017
Read More
University of Ljubljana discloses BChE inhibitors
Read More
Cocrystal Pharma introduces NS5B inhibitors
Read More
Combination of FLT3 inhibitor and homoharringtonine shows promise in FLT3-ITD acute myeloid leukemia
Read More
Merck & Co. patents HIV integrase inhibitors
Read More
GlaxoSmithKline discovers BET inhibitors
Read More
Crescendo and Takeda enter global collaboration for Humabody-based therapeutics
Read More
Taisho Pharmaceutical reports compounds useful for RSV infection
Read More
Piramal Enterprises to acquire Janssens injectable anesthesia and pain management products
Read More
Apta-1 demonstrates great potential in preclinical studies
Read More
Meiji Seika opens phase I pharmacokinetic bioequivalence study of DMB-3113 and adalimumab in Japan
Read More
LY-3023414 and necitumumab combination appears safe in non-small cell lung cancer
Read More
Cellceutix reports early positive results for brilacidin trial
Read More
Signs of efficacy seen with anti-PD-1 monoclonal antibody MEDI-0680 in phase I trial
Read More
Xenetic Biosciences reports positive data from phase II trial of erepoxen
Read More
Nordic Nanovector enters collaboration with Legochem Bioscience for leukemia research
Read More
FDA grants priority review to Lucentis sBLA for myopic CNV
Read More
Kymab and EpimAb sign bispecific antibody cross-licensing agreement
Read More
NIH grant supports work at OHSU in Fanconi's anemia
Read More
3SBio announces commercialization license agreement for Byetta and Bydureon in China
Read More
Addex initiates study of ADX-88178 in nonhuman primate model of cocaine addiction
Read More
First-in-human study finds FGFR inhibitor BAY-1163877 is well tolerated
Read More
FDA grants breakthrough therapy designation to Gamida Cell's NiCord
Read More
Disease control seen in first-in-human trial of NVP-CGM-097 in advanced solid tumors
Read More
Milestone in USP partnership between Hybrigenics and Servier
Read More
Nusinersen MAA submitted to EMA
Read More